Chiba, Japan

Fujiko Konno



Average Co-Inventor Count = 8.6

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Tomisato, JP (1995)
  • Tomisato-machi, JP (1999 - 2001)
  • Chiba, JP (1995 - 2005)

Company Filing History:


Years Active: 1995-2005

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Fujiko Konno: Innovator in Pharmaceutical Chemistry

Introduction

Fujiko Konno is a prominent inventor based in Chiba, Japan, known for her significant contributions to pharmaceutical chemistry. With a total of seven patents to her name, she has made remarkable advancements in the field of drug development.

Latest Patents

Among her latest patents is an invention related to imidazole derivatives or salts thereof, which are aimed at creating drugs that effectively inhibit the production of nitric oxide (NO) and interleukin-6 (IL-6). This innovation is particularly useful for preventing or treating diseases that arise from the overproduction of these compounds. Another notable patent involves a substituted piperidine derivative designed for treating urinary disturbances, showcasing her versatility in addressing various medical conditions.

Career Highlights

Fujiko Konno has worked with reputable companies such as Ss Pharmaceutical Co., Ltd. and Hisamitsu Medical Co., Ltd. Her work in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to the development of effective pharmaceutical solutions.

Collaborations

Throughout her career, Fujiko has collaborated with esteemed colleagues, including Hideaki Matsuda and Terumitsu Kaihoh. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Fujiko Konno's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a key innovator in the industry. Her work continues to impact the field positively, paving the way for future advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…